These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 36444232)

  • 1. AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects:
    Wechalekar AD; Fontana M; Quarta CC; Liedtke M
    JACC CardioOncol; 2022 Nov; 4(4):427-441. PubMed ID: 36444232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATTR Amyloidosis: Current and Emerging Management Strategies:
    Griffin JM; Rosenthal JL; Grodin JL; Maurer MS; Grogan M; Cheng RK
    JACC CardioOncol; 2021 Oct; 3(4):488-505. PubMed ID: 34729521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management.
    Witteles RM; Liedtke M
    JACC CardioOncol; 2019 Sep; 1(1):117-130. PubMed ID: 34396169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies:
    Bianchi G; Zhang Y; Comenzo RL
    JACC CardioOncol; 2021 Oct; 3(4):467-487. PubMed ID: 34729520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMR-based differentiation of AL and ATTR cardiac amyloidosis.
    Dungu JN; Valencia O; Pinney JH; Gibbs SD; Rowczenio D; Gilbertson JA; Lachmann HJ; Wechalekar A; Gillmore JD; Whelan CJ; Hawkins PN; Anderson LJ
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):133-42. PubMed ID: 24412186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Resonance in Transthyretin Cardiac Amyloidosis.
    Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Zumbo G; Knight DS; Kotecha T; Francis R; Hutt DF; Rezk T; Rosmini S; Quarta CC; Whelan CJ; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Am Coll Cardiol; 2017 Jul; 70(4):466-477. PubMed ID: 28728692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.
    Martinez-Naharro A; Patel R; Kotecha T; Karia N; Ioannou A; Petrie A; Chacko LA; Razvi Y; Ravichandran S; Brown J; Law S; Quarta C; Mahmood S; Wisniowski B; Pica S; Sachchithanantham S; Lachmann HJ; Moon JC; Knight DS; Whelan C; Venneri L; Xue H; Kellman P; Gillmore JD; Hawkins PN; Wechalekar AD; Fontana M
    Eur Heart J; 2022 Dec; 43(45):4722-4735. PubMed ID: 36239754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains.
    Slivnick JA; Alvi N; Singulane CC; Scheetz S; Goyal A; Patel H; Sarswat N; Addetia K; Fernandes F; Vieira MLC; Cafezeiro CRF; Carvalhal SF; Simonetti OP; Singh J; Lang RM; Zareba KM; Patel AR
    Eur Heart J Cardiovasc Imaging; 2023 May; 24(6):829-837. PubMed ID: 36624559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Troponin in Patients With Light Chain and Transthyretin Cardiac Amyloidosis:
    De Michieli L; Cipriani A; Iliceto S; Dispenzieri A; Jaffe AS
    JACC CardioOncol; 2024 Feb; 6(1):1-15. PubMed ID: 38510286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Fontana M; Pica S; Reant P; Abdel-Gadir A; Treibel TA; Banypersad SM; Maestrini V; Barcella W; Rosmini S; Bulluck H; Sayed RH; Patel K; Mamhood S; Bucciarelli-Ducci C; Whelan CJ; Herrey AS; Lachmann HJ; Wechalekar AD; Manisty CH; Schelbert EB; Kellman P; Gillmore JD; Hawkins PN; Moon JC
    Circulation; 2015 Oct; 132(16):1570-9. PubMed ID: 26362631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis.
    Zhang KW; Stockerl-Goldstein KE; Lenihan DJ
    JACC Basic Transl Sci; 2019 Jun; 4(3):438-448. PubMed ID: 31312767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
    Cui Q; Yu J; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist.
    Papathanasiou M; Carpinteiro A; Rischpler C; Hagenacker T; Rassaf T; Luedike P
    Int J Cardiol Heart Vasc; 2020 Jun; 28():100519. PubMed ID: 32373710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.
    Cai S; Haghbayan H; Chan KKW; Deva DP; Jimenez-Juan L; Connelly KA; Ng MY; Yan RT; Yan AT
    Int J Cardiol; 2024 May; 403():131892. PubMed ID: 38382853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient.
    Vergaro G; Castiglione V; Poletti R; Buda G; Pucci A; Musetti V; Genovesi D; Aimo A; Passino C; Emdin M
    JACC Case Rep; 2021 Mar; 3(3):450-454. PubMed ID: 34317556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.
    Al Saleh AS; Sidiqi MH; Muchtar E; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Warsame RM; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1520-1525. PubMed ID: 31054986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial.
    Shen KN; Fu WJ; Wu Y; Dong YJ; Huang ZX; Wei YQ; Li CR; Sun CY; Chen Y; Miao HL; Zhang YL; Cao XX; Zhou DB; Li J
    Circulation; 2022 Jan; 145(1):8-17. PubMed ID: 34503349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.